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Vav and SLP-76 Interact and Functionally
Cooperate in IL-2 Gene Activation
Jun Wu,* David G. Motto,³ the recently cloned SLP-76 (Jackman et al., 1995; Weiss
and Littman, 1994). Although tyrosine phosphorylationGary A. Koretzky,³§‖ and Arthur Weiss*²
*Department of Microbiology and Immunology of PLC-g1 induces its enzymatic activity, leading to the
activation of the inositol phospholipid pathway, the sig-²Department of Medicine
Howard Hughes Medical Institute nificance of the tyrosine phosphorylation of Vav and
SLP-76 remains unclear.University of California at San Francisco
San Francisco, California 94143 The proto-oncogene Vav was first identified as a result
of its transforming activity during the course of an onco-³Department of Physiology and Biophysics
§Department of Internal Medicine gene search of esophageal carcinoma DNA (Katzav et
al., 1989). However, its transforming potential in fibro-‖Graduate Program in Immunology
University of Iowa blasts was shown to be due to the removal of its
N-terminal 67 aa (Coppola et al., 1991; Katzav et al.,College of Medicine
Iowa City, Iowa 52242 1989, 1991). Vav contains a number of interesting struc-
tural motifs, including a putative guanine nucleotide ex-
change factor (GEF) domain for the Rho/Rac/CDC42
families of small GTPases, a pleckstrin homology (PH)Summary
domain, which may participate in membrane localiza-
tion, a cysteine-rich (C-rich) domain, which may formT cell antigen receptor (TCR) stimulation induces tyro-
zinc fingers, as well as two Src homology 3 (SH3) do-sine phosphorylation of many intracellular proteins,
mains and a Src homology 2 (SH2) domain at its Cincluding the proto-oncogene Vav, which is expressed
terminus, which are presumably involved in protein±exclusively in hematopoieticand trophoblast cells. Vav
protein interactions (Adams et al., 1992; Boguski andis critical for lymphocyte development and activation.
McCormick, 1993; Boguski et al., 1992; Galland et al.,Overexpression of Vav in Jurkat T cells leads to poten-
1992; Koch et al., 1991). Vav is expressed exclusivelytiation of TCR-mediated IL-2 gene activation. How-
in hematopoietic and trophoblast cells (Katzav et al.,ever, the biochemical function of Vav is unknown.
1989; Zmuidzinas et al., 1995), and is readily tyrosineHere, we demonstrate that the major induced tyrosine
phosphorylated in response to a variety of stimuli, in-phosphoprotein associated with Vav is thehematopoi-
cluding stimulation of TCR, B cell antigen receptoretic cell-specific SLP-76. The Vav SH2 domain is re-
(BCR), and various cytokine receptors (Bustelo and Bar-quired for this interaction and for TCR-mediated Vav
bacid, 1992; Bustelo et al., 1992; Evens et al., 1993;tyrosine phosphorylation. Similar to Vav, overexpres-
Margolis et al., 1992). Its structure, expression, and tyro-sion of SLP-76 markedly potentiates TCR-mediated
sine phosphorylation pattern suggests an important roleNF-AT and IL-2 gene activation. Furthermore, overex-
in signal transduction pathways in lymphocytes.pression of both Vav and SLP-76 synergistically in-
The importance of Vav in lymphocyte developmentduces basal and TCR-stimulated NF-AT activation.
and activation was demonstrated recently in both miceThese results suggest that a signaling complex con-
and cell lines. Germline inactivation of the vav genetaining Vav and SLP-76 plays an important role in lym-
results in early embryonic lethality, suggesting its criticalphocyte activation.
role in trophoblast development (Zmuidzinas et al.,
1995). Chimeric mice derived from blastocysts lacking
Introduction the recombinase-activating gene (RAG) and embryonic
stem (ES) cells deficient in Vav expression displayed
The T lymphocyte antigen receptor (TCR) recognizes a dramatic reduction in thymocyte number as well as
pathogens or foreign antigens and initiates a series of peripheral T and B cells (Fischer et al., 1995; Tarakhov-
intracellular biochemical events that result in biological sky et al., 1995; Zhang et al., 1995). Moreover, the Vav-
responses. These signal transduction events are crucial deficient mature T and B cells showed a profound defect
to both T cell development and T cell±mediated immune in proliferation and cytokine production in response to
responses. One of the earliest biochemical events fol- TCR and BCR stimulation. The defect in Vav2/2 chimeras
lowing ligation of the TCR is the activation of Src family appeared to be specific to TCR and BCR signaling path-
protein tyrosine kinases (PTKs) such as Lck and Fyn, ways, since the Vav2/2 T cells could proliferate when
which leads to phosphorylation of tyrosine residues exogenous interleukin-2 (IL-2) was added. Similarly, li-
within the immunoreceptor tyrosine-based activation popolysaccharide or CD40 ligand stimulation could also
motifs (ITAMs) in the TCR z and CD3 chains (Weiss and induce Vav2/2 B cell proliferation. The block in Vav2/2
Littman, 1994). The phosphorylation of ITAMs results in T cellsappears tobe in a proximalcomponent of the TCR
the subsequent recruitment and activation of Syk/ZAP- signaling pathway, since the defect could be rescued by
70 family PTKs (Chan et al., 1991, 1992, 1994; Iwashima treatment with phorbol ester and ionomycin, pharmaco-
et al., 1994; Wange et al., 1992). The activation of Src logical agents that mimic the downstream events in-
family and Syk/ZAP-70 PTKs leads to the phosphoryla- duced by TCR stimulation and consequently induce IL-2
tion of many downstream substrates including phos- production.
The involvement of Vav in TCR signal transductionpholipase-C g1 (PLC-g1), the proto-oncogene Vav, and
Immunity
594
was also demonstrated in the human leukemic Jurkat al., 1996). In this report, we show that SLP-76 and Vav
T cell line (Wu et al., 1995). Overexpression of Vav led act synergistically to induce NF-AT activation, sug-
to a marked increase in basal nuclear factor of activated gesting that a complex containing Vav and SLP-76 plays
cells (NF-AT) or IL-2-driven transcriptional activity, an important role in TCR-mediated IL-2 gene activation.
which was further enhanced by TCR stimulation. This
Vav-induced NF-AT activation appeared to be specific Results
to the TCR, since it had no effect on NF-AT induction
induced by the G protein±coupled human muscarinic Vav and SLP-76 Interact in Jurkat T Cells
receptor. Overexpression of Vav had no effect on phor- To identify potential regulators or effectors of Vav, we
bol ester and ionomycin-induced NF-AT activation but immunoprecipitated Vav from Jurkat T cell lysates, re-
required calcineurin and Ras to induce NF-AT, further solved the precipitates by SDS±PAGE, and immunoblot-
supporting the involvement of Vav in the proximal events ted the gels with anti-phosphotyrosine antibodies. Fol-
of TCR signaling. Finally, a functional TCR complex was lowing TCR stimulation, the tyrosine phosphorylation of
required for this Vav activity. These results are consis- Vav was markedly increased when compared with Vav
tent with the findings in Vav2/2 chimeric mice and pro- precipitates from unstimulated cells. In addition, a sec-
vide further evidence that Vav plays an important role ond phosphoprotein of 76 kDa coprecipitated with Vav
in proximal events involved in TCR signaling. following receptor engagement (Figure 1A). A 76 kDa
Recent approaches towards studying the function of phosphoprotein was also found to be associated with
Vav have focused on identifying proteins that interact Vav upon antigen receptor stimulation in thymocytes
with Vav in lymphocytes. Although Vav has not been (data not shown; Gouy et al., 1995). By blotting the Vav
found to associate directly with antigen receptors fol- immunoprecipitates with antisera against known tyro-
lowing ligand stimulation in T and B cells, a number sine-phosphorylated proteins with similar molecular
of proteins have been reported to interact with Vav, mass, we determined that this 76 kDa Vav-associated
including an RNA-binding protein (hnRNP K), Ku-70, phosphoprotein was not Syk, ZAP-70, Itk, Tec, paxillin,
Grb-2, JAK family members, Lck, ZAP-70, and tubulin or CD5 (data not shown). Recently, a 76 kDa protein,
(Bustelo et al., 1995; Hobert et al., 1994; Gupta et al., SLP-76, was cloned from Jurkat T cells. Interestingly,
1994; Huby et al., 1995; Katzav et al., 1994; Matsuguchi similar to Vav, SLP-76 is expressed specifically in hema-
et al., 1995; Romero et al., 1996; Ye and Baltimore,1994).
topoietic cells and also becomes tyrosine phosphory-
Unfortunately, the functional significance of these inter-
lated upon TCR or BCR stimulation. Therefore, we at-
actions remains unclear, since many of these associa-
tempted to determine whether SLP-76 was the 76 kDa
tions were characterized by using GST fusion proteins
phosphoprotein associated with Vav. As shown in Figureor the yeast two-hybrid system. However, an unknown
1B, SLP-76 could be detected in Vav immunoprecipi-
70±75 kDa tyrosine-phosphorylated protein has been
tates from Jurkat lysates by Western blotting using anreproducibly shown to associate with Vav in cells follow-
anti-SLP-76±specific antiserum. Conversely, Vav coulding antigen receptor stimulation in thymocytes, T cells,
also be coimmunoprecipitated with this anti-SLP-76 an-and B cells (Bustelo et al., 1992; Gouy et al., 1995; Katzav
tiserum (Figure 1C). There does appear to be a varyinget al., 1994). Therefore, we attempted to identify this
degree of basal association between Vav and SLP-76phosphoprotein in an effort to investigate the function
in Jurkat cells (Figures 1B and 1C; data not shown).of Vav in T cells.
However, this association could be further induced byHere, we identify this tyrosine-phosphorylated protein
TCR stimulation or by treatment with pervanadate, aas the newly cloned 76 kDa SLP-76. SLP-76 was identi-
tyrosine phosphatase inhibitor that induces high levelsfied first through its association with GST±Grb2 fusion
of cellular tyrosine phosphorylation.proteins in vitro (Jackman et al., 1995). It contains a
To analyze further the association between Vav andnumber of potential tyrosine phosphorylation sites in its
SLP-76, Jurkat cells containing SV40 large T antigenN terminus, an SH2 domain in its C terminus, and a
(TAg) were transiently transfected with a myc epitope-central proline-rich region that may interact with SH3
tagged form of Vav. These transfected cells were thendomain-containing proteins such as Grb2 (Motto et al.,
lysed and Vav was immunoprecipitated with an anti-1996). Interestingly, SLP-76 is also expressed specifi-
myc epitope monoclonal antibody (MAb). As shown incally in hematopoietic cells and becomes readily tyro-
Figure 1D, SLP-76 could be readily detected in the Vavsine phosphorylated upon antigen receptor stimulation.
immunoprecipitates from myc±Vav-transfected cells fol-In this report, we show that the SH2 domain of Vav
lowing TCR stimulation. In addition, anti-phosphotyro-interacts with tyrosine-phosphorylated SLP-76 in Jurkat
sine blots revealed that the SLP-76 associated with VavT cells. Moreover, an SH2 domain mutant of Vav fails
was tyrosine phosphorylated (data not shown). It is note-to become tyrosine phosphorylated or to interact with
worthy that only a weak basal association between VavSLP-76 following TCR or BCR stimulation. Overexpres-
and SLP-76 was detected in TAg-transfected Jurkatsion of a truncated Vav protein containing its C-terminal
cells, in contrast with the results obtained with parentalSH2 and two SH3 domains blocks TCR-mediated NF-
Jurkat cells (Figures 1B and 1C). One potential explana-AT activation. This inhibitory effect is dependent upon
tion for these differences is that the interaction betweenthe SH2 domain phosphotyrosine-binding function.
Vav and SLP-76 may depend upon tyrosine phosphory-These results suggest that the interactions mediated by
lation of Vav or SLP-76, or both, since we consistentlythe Vav SH2 domain, such as the Vav±SLP-76 interac-
observed that the basal tyrosine phosphorylation leveltion, are important for TCR signaling. Interestingly, simi-
of TAg Jurkat cells was much lower than that of parentallar to Vav, overexpression of SLP-76 markedly potenti-
ates the TCR-mediated IL-2 gene activation (Motto et Jurkat cells (data not shown).
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Figure 2. SLP-76 Is the 76 kDa Vav-Associated Phosphoprotein
Jurkat cells were either left unstimulated or stimulated with C305
for 2 min. The lysates were then subject to two rounds of preclearing
with either preimmune or anti-SLP-76 antisera and subsequently
with protein G±coupled sepharose beads. The precleared lysates
were then immunoprecipitated with anti-Vav antiserum and the im-
munoprecipitates (left) or lysates (right) were blotted with anti-phos-
photyrosine MAb (4G10). Each IP lane represents approximately 5
3 107 cell equivalents. Each lysate lane represents approximately
2 3 106 cell equivalents. The closed and open arrowheads represent
the migrations of Vav and SLP-76, respectively.
To demonstrate further that SLP-76 is the only tyro-
sine-phosphorylated protein contained in the 76 kDa
band that coimmunoprecipitates with Vav, we pre-
cleared SLP-76 and then immunoprecipitated Vav from
the SLP-76-depleted Jurkat lysates. After two rounds
of depletion, over 90% of SLP-76 could be removed
from the lysates as assayed by Western blotting (data
not shown). Depletion of SLP-76 eliminated most of the
Vav-associated 76 kDa tyrosine phosphoprotein (Figure
2), indicating that the 76 kDa phosphoprotein is predom-
inantly SLP-76. Note that the band migrating at 105
kDa is likely a modified form of Vav, which has been
previously reported (Coppola et al., 1991) and could be
detected by both the anti-Vav antiserum or the anti-myc
epitope MAb (see Figure 4A; data not shown). Taken
together, these results demonstrate that in T cells, Vav
and SLP-76 interact with each other in vivo.
The SH2 Domain of Vav Interacts with SLP-76
To define the region of Vav that mediates its interaction
with SLP-76, we transiently transfected TAg Jurkat cells
with a myc epitope-tagged truncated Vav (Vav±C), con-
taining the C-terminal SH2 and two SH3 domains (aminoFigure 1. Vav and SLP-76 Interact in Jurkat T Cells
acids 538±845). Vav±C was immunoprecipitated and im-(A) Anti-phosphotyrosine (4G10) blot of normal rabbit serum (NRS)
and anti-Vav immunoprecipitates from unstimulated and TCR-stim-
ulated Jurkat T cells. Jurkat cells (5 3 107) were either left unstimu-
lated or stimulated with anti-TCR MAb (C305, 1:500 dilution) for 2
min, and subsequently lysed in NP-40 lysis buffer and immunopre- (C) Vav coimmunoprecipitates with SLP-76. Cells were processed
cipitated with the indicated antibodies as described in Experimental as in (B) and the lysates were immunoprecipitated with either preim-
Procedures. The immunoprecipitates and 2 3 106 cell equivalent mune serum or anti-SLP-76 serum. The upper and lower part of the
lysates were then blotted with anti-phosphotyrosine antibody blot were blotted with anti-Vav and anti-SLP-76 antisera, respec-
(4G10). The migrations of Vav and the 76 kDa Vav-associated tyro- tively.
sine phosphoprotein are indicated by closed and open arrowheads, (D) The myc epitope-tagged Vav associates with SLP-76. TAg Jurkat
respectively. cells were transiently transfected with either control DNA (pEFBOS)
(B) SLP-76 coimmunoprecipitates with Vav. Jurkat cells (5 3 107) or myc epitope-tagged Vav (pEF115myc). After transfection (20±40
were either left unstimulated, stimulated with C305, or treated with hr), 1±2 3 107 live cells were either left unstimulated or stimulated
pervanadate. The lysates were immunoprecipitated with either NRS with anti-TCR MAb (C305, 1:500) for 2 min and then lysed. The
or anti-Vav antiserum. The upper part of the blot was blotted with lysates were immunoprecipitated with anti-myc MAb (9E10), and
anti-Vav antiserum, whereas the lower part was blotted with anti- the upper and lower parts of the blot were blotted with anti-myc
SLP-76 antiserum. MAb and anti-SLP-76 antiserum, respectively.
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mune complexes were analyzed by anti-phosphotyro-
sine Western blot. Following receptor stimulation, a
prominent 76 kDa tyrosine phosphoprotein was coim-
munoprecipitated with Vav±C (Figure 3A). Immunoblot
analysis confirmed that this phosphoprotein was SLP-
76 (data not shown), indicating that the C-terminal por-
tion of Vav is sufficient to mediate the interaction be-
tween Vav and SLP-76. Interestingly, Vav±C also be-
came tyrosine phosphorylated following TCR ligation,
demonstrating that the C-terminal region contains Vav
tyrosine phosphorylation sites.
The inducible association between Vav and SLP-76
suggests a possible SH2 domain±phosphotyrosine in-
teraction. Previous in vitro studies indicated that the
SH2 domain of Vav could interact with a number of
tyrosine phosphoproteins in lymphocytes (Bustelo et
al., 1992; Katzav et al., 1994). To examine whether the
association between Vav and SLP-76 is mediated by
the SH2 domain of Vav, a bacterial GST fusion protein
containing the Vav SH2 domain was used to bind tyro-
sine phosphoproteins in Jurkat lysates. As shown in
Figure 3B, GST±VavSH2 selectively bound to two major
tyrosine-phosphorylated proteins of 76 kDa and 70 kDa
following TCR stimulation. These interactions were likely
to be mediated by the SH2 domain and phosphotyrosine
interactions, since the addition of phenyl phosphate
could completely disrupt both these associations (Fig-
ure 3B). Both preclearing and direct Western blotting
experiments using the appropriate antisera revealed
that the 76 kDa and 70 kDa phosphoproteins were SLP-
76 and ZAP-70, respectively (Figure 3C; data not shown).
Note that SLP-76 depletion did not reduce the amount
of ZAP-70 associated with GST±VavSH2 and vice versa
(Figure 3C), suggesting that these interactions likely in-
volve separate complexes. Unlike the Vav±SLP-76 asso-
ciation, the interaction between Vav and ZAP-70 ap-
peared to occur at a much lower stoichiometry or may
be more transient, since it was difficult to detect in vivo
(see Figure 1A; data not shown), although it has been
possible to demonstrate in other studies (Katzav et al.,
1994; Gouy et al., 1995). Taken together, these data
indicate that the Vav SH2 domain is sufficient to interact
with SLP-76 following TCR stimulation.
The Vav SH2 Domain Is Necessary for Both
the Vav±SLP-76 Interaction and Optimal
TCR-Stimulated Vav Tyrosine Phosphorylation
When Vav is introduced into fibroblasts, it is inducibly
tyrosine phosphorylated upon epidermal growth factor
Figure 3. The Vav SH2 Domain Can Interact with SLP-76 with anti-phosphotyrosine MAb (4G10). Each protein precipitation
(A) The C-terminal portion of Vav is sufficient for interacting with lane represents approximately 5 3 107 cell equivalents and each
SLP-76. TAg Jurkat cells were transiently transfected with Vav±C lysate lane represents 2 3 106 cell equivalents. The closed and
(pEFVav±Cmyc) and processed as described in Figure 1D. The ly- open arrowheads indicate the 76 kDa and 70 kDa phosphoproteins
sates were immunoprecipitated with anti-myc MAb (9E10) and the associated with GST±VavSH2 fusion protein.
immunoprecipitates were blotted with anti-phosphotyrosine MAb (C) GST±VavSH2 fusion protein interacts with SLP-76 and ZAP-70.
(4G10) (lanes 1 and 2). The whole cell lysates are shown in lanes 3 Jurkat cells were either left unstimulated or stimulated with C205 for
and 4. The migrations of SLP-76 and Vav±C are indicated by closed 2 min. The lysates were first precleared twice with either preimmune
and open arrowheads, respectively. serum, anti-SLP-76 antiserum, or anti-ZAP-70 antiserum and then
(B) GST±VavSH2 fusion protein precipitations of Jurkat lysates. Jur- precleared with GST alone. The precleared lysates were then precip-
kat cells were either left unstimulated or stimulated with C305 for itated with either GST aloneor GST±VavSH2 and the protein precipi-
2 min. The lysates were first precleared with GST alone and then tates were blotted with anti-phosphotyrosine MAb (4G10). Each pro-
mixed with either GST alone or GST fusion protein containing the tein precipitation lane represents approximately 5 3 107 cell
Vav SH2 domain (GST±VavSH2) in the absence or presence of 50 equivalents. The migrations of SLP-76 and ZAP-70 are indicated by
mM phenyl phosphate. The protein complexes were then blotted the closed and open arrowheads, respectively.
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or platelet-derived growth factor receptor stimulation
(Bustelo et al., 1992; Margolis et al., 1992). Activation of
these receptors also leads to binding of Vav to these
receptors via its SH2 domain, suggesting that the Vav
SH2 domain may mediate the recruitment of Vav to these
receptors where it can be tyrosine phosphorylated. The
TCR-mediated Vav±C tyrosine phosphorylation de-
scribed above is also consistent with this hypothesis.
Therefore, we generated an SH2 domain point mutant
of Vav and examined its tyrosine phosphorylation status
as well as its ability to associate with SLP-76 in Jurkat
T cells. Substitution of an arginine residue with lysine
(VavSH2RK) within the predicted phosphate-binding
site of the Vav SH2 domain markedly reduced its TCR-
induced tyrosine phosphorylation, as compared with the
wild type (Figure 4A). Similarly, we found that the SH2
domain of Vav was also required for its BCR-induced
tyrosine phosphorylation in chicken DT40 B cells (data
not shown). These data demonstrate that the Vav SH2
domain is important for TCR- or BCR-induced tyrosine
phosphorylation of Vav.
The SH2 mutant of Vav (VavSH2RK) also failed to
associate with SLP-76 following TCR stimulation (Figure
4B).Since SLP-76 also contains an SH2 domain that may
interact with tyrosine-phosphorylated Vav, one possible
explanation for the loss of the association between
VavSH2RK and SLP-76 is that the SH2 domain of SLP-76
could not bind to the weakly phosphorylated VavSH2RK.
Figure 4. The Vav SH2 Domain Is Necessary for TCR-Induced VavThis appeared to be unlikely, since a GST fusion protein
Tyrosine Phosphorylation and Vav±SLP-76 Interactioncontaining the SLP-76 SH2 domain failed to bind to
(A) TCR-induced tyrosine phosphorylations of wild-type and an SH2tyrosine-phosphorylated Vav (data not shown; Motto et
domain point mutant of Vav. TAg Jurkat cells were transientlyal., 1996). Taken together, these data demonstrate that
transfected with either myc epitope-tagged wild-type Vav (pEF115-
the Vav SH2 domain is both necessary and sufficient myc) or an SH2 domain mutant of Vav (pEF115mycRK). After trans-
for mediating the interaction between Vav and SLP-76 fection (20±40 hr), 1±2 3 107 live cells were either left unstimulated
following TCR stimulation. or stimulated with anti-TCR MAb (C305, 1:1000) for 2 min and then
lysed. The lysates were immunoprecipitated with anti-myc MAb
(9E10) and blotted with anti-phosphotyrosine MAb (4G10) (top). TheThe Interaction(s) Mediated by Vav SH2
blot was then stripped and reblotted with anti-myc MAb (9E10)Domain Is Important for TCR Signaling
(bottom).
The early biochemical events induced by TCR stimula- (B) VavSH2RK fails to associate with SLP-76. TAg Jurkat cells were
tion, through poorly understood mechanisms, lead to transfected and stimulated as described in (A). The lysates were
gene induction and other T cell effector functions. Re- immunoprecipitated with anti-myc MAb (9E10). The upper part of
the blot was blotted with anti-myc MAb (9E10) (top), whereas theporter constructs containing multiple copies of the NF-
lower part was blotted with anti-SLP-76 antiserum (bottom).AT binding site or the entire IL-2 promoter and regulatory
elements have been useful tools to monitor TCR-medi-
ated signaling events. We previously showed that over-
This point mutation completely abolished the inhibitoryexpression of Vav in Jurkat T cells leads to a marked
effect induced by overexpression of Vav±C, suggestingincrease of basal and TCR-stimulated NF-AT and IL-2
that the NF-AT inhibition was dependent upon the phos-promoter activities (Wu et al., 1995). Since the C termi-
photyrosine binding function of the Vav SH2 domain.nus of Vav (Vav±C) is sufficient to interact with SLP-76
Overexpression of Vav-C may compete with the endoge-and to become tyrosine phosphorylated following TCR
nous Vav to form complexes with SLP-76 or to interactstimulation, we attempted to determine whether overex-
with PTKs responsible for Vav tyrosine phosphorylation,pression of Vav±C was also sufficient to induce NF-AT
thereby acting as a dominant negative to inhibit TCRactivation in Jurkat cells. In contrast with the full-length
signaling. These data suggest that the interaction(s) me-Vav, overexpression of Vav±C not only completely failed
diated by Vav SH2 domain, such as the Vav±SLP-76to induce basal NF-AT activity, but also inhibited TCR-
interaction, is important for TCR signalingevents leadingstimulated NF-AT induction (Figure 5), suggesting that
to NF-AT activation.the effector domain of Vav may reside in its N-terminal
region. To map the region responsible for this inhibitory
SLP-76 and Vav Functionally Cooperateeffect, we examined the mutant of Vav±C (Vav±CSH2RK)
in TCR-Mediated IL-2 Gene Activationin which the arginine residue within the phosphotyrosine
To address further the functional significance of thebinding pocket of the SH2 domain was substituted with
interaction between Vav and SLP-76, we overexpressedlysine. The levels of Vav±C and Vav±CSH2RK were com-
parablewhen assayed by Western blot (data not shown). SLP-76 in Jurkat cells and examined its effect on the
Immunity
598
Figure 5. Overexpression of the C-Terminal Vav Inhibits TCR-Medi-
ated NF-AT Activation
Jurkat T cells were cotransfected with 20 mg of NF-AT±Luc together
with 20 mg of either an empty vector (vector), the C-terminal Vav
(Vav±C), or an SH2 domain point mutant of Vav±C (Vav±CSH2RK).
Cells were either unstimulated or stimulated with anti-TCR MAb
(C305, 1:1000) and subsequently assayed for luciferase activity. The
results are shown as the percent of the maximal stimulation for each
transfection condition induced by treatment with PMA (50 ng/ml)
plus ionomycin (1 mM). The maximum NF-AT responses for this
experiment were approximately 1.5 3 105 arbitrary light units (AU)
and did not differ significantly between different transfection condi-
tions. Luciferase activity was determined in triplicate in each experi-
mental condition. The data are representative of two independent
experiments.
NF-AT or IL-2-driven promoters. Unlike Vav, and as we
have recently reported (Motto et al., 1996), overexpres-
sion of SLP-76 only led to minimal basal induction of
NF-AT (Figure 6A). Similar to Vav, however, overexpres-
sion of SLP-76 dramatically synergized with TCR stimu-
lation to activate NF-AT and IL-2 transcriptional activity
Figure 6. Overexpression of Either Vav or SLP-76 Potentiates TCR-
(Figures 6A and 6B; Motto et al., 1996), suggesting its Induced NF-AT and IL-2 Responses
involvement in events leading to IL-2 gene activation. Jurkat T cells were cotransfected with 20 mg of NF-AT±Luc (A) or
Since Vav and SLP-76 interact in T cells, we cotrans- IL-2±Luc (B) together with 40 mg of either an empty vector (vector),
fected various amounts of SLP-76 or Vav cDNAs, or SLP-76, or Vav, as described in Experimental Procedures. Cells
were either unstimulated or stimulated with either anti-TCR MAbboth, into Jurkat cells to address whether they could
(C305, 1:1000) (A) orC305 plus PMA (50 ng/ml) (B), and subsequentlycooperate to influence the TCR-mediated NF-AT re-
assayed for luciferase activity. The results are shown as the percentsponses. Coexpression of SLP-76 and Vav led to a dose-
of the maximal stimulation for each transfection condition induced
dependent synergy in basal NF-AT induction (Figure 7A). by treatment with PMA (50 ng/ml) plus ionomycin (1 mM) (maximum
The synergy between SLP-76 and Vav could also be responses). The maximum NF-AT or IL-2 responses were approxi-
observed at lower doses of DNA when the TCR was mately 2±4 3 105 AU. Luciferase activity was determined in duplicate
or triplicate in each experimental condition. The data are representa-engaged (Figure 7B). However, at higher doses of DNA
tive of at least two independent experiments.the synergy decreased, suggesting that some compo-
nents of the signaling pathway may be near saturation
following receptor stimulation. Taken together, these
data demonstrate that SLP-76 and Vav not only physi- gene Vav. Recent studies showed that Vav is critical for T
cally interact in T cells but functionally cooperate in the and B cell development and antigen receptor±mediated
TCR signaling pathway leading to IL-2 gene activation. activation (Fischer et al., 1995; Tarakhovsky et al., 1995;
Zhang et al., 1995; Wu et al., 1995). In this report, we
demonstrate that another hematopoietic cell-specificDiscussion
protein, SLP-76, interacts with Vav in T cells and that
the association is induced by TCR stimulation. Our studyOne immediate and obligatory consequence of trig-
gering the TCR is the tyrosine phosphorylation of multi- demonstrates further that the interaction between Vav
and SLP-76 is mediated by the SH2 domain of Vav.ple intracellular substrates, including the proto-onco-
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as the Vav±SLP-76 association, are important in events
leading to downstream NF-AT induction. Similar to Vav,
overexpression of SLP-76 in Jurkat T cells markedly
potentiated TCR-mediated NF-AT and IL-2 gene activa-
tion. Moreover, SLP-76 and Vav could synergistically
activate basal and TCR-induced NF-AT activation. Thus,
our data implicate the involvement of a complex be-
tween Vav and SLP-76 in TCR signaling events leading
to IL-2 gene activation.
Since Vav becomes tyrosine phosphorylated follow-
ing TCR stimulation and PTK activity is required for the
Vav-mediated NF-AT activation in Vav-overexpressing
Jurkat cells (Wu et al., 1995), its tyrosine phosphorylation
is likely to be important for its function. We demon-
strated that a point mutation within the SH2 domain
of Vav markedly reduces Vav tyrosine phosphorylation
following TCR stimulation, suggesting that the SH2 do-
main of Vav is important in mediating the recruitment
and tyrosine phosphorylation of Vav in T cells. Vav±C
contains the SH2 domain and becomes tyrosine phos-
phorylated following TCR stimulation. Thus, its overex-
pression could potentially compete with endogenous
Vav for TCR-induced recruitment, tyrosine phosphoryla-
tion, or both, thereby interfering with TCR signaling.
Our data provide two potential mechanisms by which
Vav becomes tyrosine phosphorylated following TCR
stimulation. Since SLP-76 is the major tyrosine-phos-
phorylated protein associated with Vav in vivo, it may
function as an adaptor for Vav tyrosine phosphorylation.
TCR stimulation could lead to tyrosine phosphorylation
of SLP-76, which could then recruit Vav via the Vav SH2
domain to the proximity of a PTK, thereby allowing Vav
to become phosphorylated. Alternatively, Vav may be
directly recruited by a PTK, e.g., ZAP-70, for its tyrosine
phosphorylation. In fibroblasts, stimulation of the epi-
dermal growth factor or platelet-derived growth factor
receptors results in autophosphorylation of their cyto-
plasmic tails, providing the binding sites for the down-
stream molecules such as PLC-g1 via their SH2 do-
Figure 7. Overexpression of Both Vav and SLP-76 Synergistically mains, which then lead to tyrosine phosphorylation and
Induces Basal and TCR-Stimulated NF-AT Activation
activation of these molecules (Koch et al., 1991). Al-
Jurkat cells were cotransfected with 20 mg of NF-AT±Luc together though the TCR and BCR do not possess intrinsic tyro-with the indicated amount of either empty vector, Vav, SLP-76, or
sine kinase activity, the Syk/ZAP-70 kinase family mem-Vav plus SLP-76. Cells were either unstimulated (A) or stimulated
bers have been shown to interact with the receptor ITAMwith anti-TCR MAb (C305, 1:1000) (B), and subsequently assayed
for luciferase activity. The results are shown as the fold induction motifs following receptor stimulation (Weiss and Litt-
of luciferase activity as compared with the activity in unstimulated man, 1994). This recruitment results in tyrosine phos-
cells transfected with 2 mg of empty vector, which is approximately phorylation and activation of these kinases. Phosphory-
200 AU. Luciferase activity was determined in triplicate in each
lated tyrosine residues within the PTKs may provideexperimental condition. The data are representative of two indepen-
further binding sites for other downstream SH2 domain-dent experiments.
containing proteins such as Vav. In this study and else-
where (Katzav et al., 1994), we showed that the GST±
VavSH2 fusion protein could bind to phosphorylatedInterestingly, a point mutation in the phosphotyrosine
ZAP-70 following TCR stimulation. The predepletion ex-binding pocket of the SH2 domain of Vav not only abol-
periments revealed that this in vitro binding was notished the TCR-induced association of Vav with SLP-76,
dependent upon the presence of SLP-76 (Figure 4A),but also markedly reduced TCR-stimulated Vav tyrosine
suggesting that Vav may interact directly with ZAP-70phosphorylation, suggesting that the SH2 domain of
via the Vav SH2 domain. It is conceivable that the tyro-Vav may also serve a critical role in TCR-induced Vav
sine phosphorylation of Vav then induces a conforma-tyrosine phosphorylation. Furthermore, overexpression
tional change, which allows it to dissociate from ZAP-70of a truncated form of Vav, containing the C-terminal
and to interact with SLP-76 for other cellular functions. InSH2 and two SH3 domains, blocked TCR-mediated NF-
fact, the low stoichiometric association in vivo betweenAT activation. This inhibitory effect was abrogated com-
Vav and ZAP-70 suggests that the interaction may bepletely by a point mutation in the Vav SH2 domain, sug-
gesting that interactions mediated by this region, such very transient. SH2 domains can provide specificity in
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signaling processes by binding to specific phosphotyro- and SH2 domains and may involve the GEF domain. A
detailed mutagenesis study of Vav should help to iden-sine-containing sequences. The degenerate phospho-
peptide library approach has predicted multiple poten- tify its functional domains.
The results of this study provide direct evidence fortial Vav SH2 domain-binding sequences, including the
sequence YESP (Songyang et al., 1994). SLP-76 con- an activation-dependent interaction between two hema-
topoietic-specific molecules, Vav and SLP-76.The asso-tains two motifs of YESP, which likely serve as the bind-
ing sites for the Vav SH2 domain. Interestingly, the same ciation appears to play an important role in TCR signal
transduction. Since bothVav and SLP-76 contain a num-motif is also present in ZAP-70 (Y315) and in Syk (Y348).
Experiments are underway to determine whether these ber of structural motifs that may potentially interact with
other signaling molecules, the association between Vavtyrosine residues are important in mediating Vav phos-
phorylation and other downstream TCR signaling and SLP-76 may further induce formation of a multipro-
tein signaling complex, which in turn functions coopera-events.
It is interesting that, although structurally unrelated tively to influence the downstream events leading to
IL-2 gene induction. In fact, it has been shown that SLP-to Vav, overexpression of SLP-76 in T cells also dramati-
cally potentiates TCR-mediated NF-AT activation. This 76 also becomes associated with pp36 and tyrosine-
phosphorylated proteins of 62 kDa and 130 kDa (Mottosuggests that SLP-76 plays a role in the TCR signaling
cascade and is likely to be a critical component in the et al., 1996). Hence, overexpression of the C terminus
of Vav may compete with the endogenous Vav to formpathway. SLP-76 was initially cloned through its in vitro
association with GST fusion protein containing Grb-2, nonfunctional complexes with SLP-76 and other pro-
teins, and thereby block TCR signaling. Future biochem-a known adaptor critical for Ras activation (Jackman et
al., 1995). This in vitro interaction between Grb-2 and ical and genetic analyses may help to elucidate the
mechanisms by which Vav and SLP-76 function in lym-SLP-76 is mediated by the SH3 domain of Grb-2 and
the proline-rich sequence in SLP-76 (Motto et al., 1996). phocytes.
It has been shown that, following TCR stimulation, both
Experimental ProceduresGrb-2 and PLC-g1 become associated with an unknown
36 kDa tyrosine-phosphorylated protein (pp36), which
DNA Constructs and Fusion Proteinsmay serve as a link between the receptor and the down-
The NF-AT and IL-2 luciferase reporter constructs were gifts from
stream Ras or PLC-g1 activation pathways, or both (Bu- Dr. G. Crabtree. The myc epitope-tagged Vav expression plasmid
day et al., 1994; Sieh et al., 1994). Interestingly, pp36 (pEF115myc) was described previously (Wu et al., 1995). The
could also be easily detected in TCR-stimulated anti- C-terminal Vav (Vav±C) was constructed by replacing the BamH1±
Kpn1 fragment of Vav cDNA from pEF115myc with an oligonucleo-SLP-76 immunoprecipitates (Motto et al., 1996). Al-
tide fragment (BamHI±KpnI) comprising both a Kozak translationalthough demonstration of an in vivo association between
initiation site and the myc epitope tag sequences, resulting in theSLP-76 and Grb-2 and the functional significance of this
plasmid pEFVav±Cmyc. Vav cDNA possessing the SH2 RK mutationcomplex are yet to be determined, these observations
(pEF115mycRK) was generated by overlapping extension polymer-
suggest that SLP-76 may play a role in the proximal ase chain reaction (PCR), using pEF115myc cDNA as a template.
TCR signaling events leading to activation of Ras or The resulting PCR product was subcloned into the pEF115myc after
removal of the corresponding wild-type sequence, resulting in thePLC-g1 pathways, or both.
plasmid pEF115mycRK. The Vav±C containing the SH2 RK mutationThe function of Vav has been an enigma. Although
was constructed by replacing the KpnI±XbaI fragment of pEFVav±Vav contains sequence homology to exchange factors
Cmyc with the corresponding fragment from pEF115mycRK, re-
for the Rac/Rho/CDC42 family of small GTPases but sulting in the plasmid pEFVav±CmycRK. The pEF/flag/SLP-76 and
not for Ras, it was reported to be the major antigen GST/SLP-76/SH2 cDNAs were described elsewhere (Motto et al.,
receptor±stimulated Ras exchange factor in lympho- 1996). The GSTVavSH2 was provided by Dr. S. Katzav (Katzav et
al., 1994). GST fusion proteins were induced and affinity purified ascytes (Gulbins et al., 1993). However, this conclusion
described (Smith and Johnson, 1988).has not been reproduced or supported by other studies.
For example, the transformation phenotype of the onco-
Antibodiesgenic Vav-transfected fibroblasts is distinct from that
The MAb used for the stimulation of the TCR was C305, which
of fibroblasts transformed by oncogenic Ras, but is simi- recognizes the Jurkat Ti b chain (Weiss and Stobo, 1984). Anti-Vav
lar to the phenotype of cells transformed by oncogenic polyclonal antibody was purchased from Santa Cruz Biotechnology
Dbl (Bustelo et al., 1994), a known Rac/Rho/CDC42 ex- (Santa Cruz, California). Sheep anti-SLP-76 antiserum was gener-
ated against amino acids 136±235 of human SLP-76 expressed aschange factor sharing homologous GEF domain with
a GST fusion protein (Motto et al., 1996). Anti-phosphotyrosine MAb,Vav (Boguski and McCormick, 1993). Moreover, onco-
4G10, was purchased from Upstate Biotechnology, Incorporatedgenic Vav- or Dbl-transformed cells did not exhibit ele-
(Lake Placid, New York). A MAb, 9E10, for the detection of the myc
vated levels of Ras±GTP (Bustelo et al., 1994; Khosravi- epitope was provided by Dr. J. M. Bishop.
Far et al., 1994). In Jurkat T cells, we and others also
showed that the effect of Vav overexpression is distinct Cell Lines and Transfections
from that of simply activating Ras pathway alone (Wu Jurkat cells (E6-1) were maintained in RPMI 1640 medium supple-
mented with 10% fetal calf serum, penicillin, streptomycin, and glu-et al., 1995; Holsinger et al., 1995). These data suggest
tamine (complete medium). TAg Jurkat cells (a gift from Dr. G.that Vav is not simply a GEF for Ras. Here, we showed
Crabtree) (Clipstone and Crabtree, 1992) were maintained in thethat in contrast with the full-length Vav, overexpression
complete medium with 2.0 mg/ml geneticin (GIBCO), and transferred
of theC-terminal Vav (Vav±C) not only failed topotentiate to geneticin-free medium 48 hr before experiments to prevent
NF-AT activity, but also appeared to function as a domi- aminoglycoside-mediated inhibition of phosphoinositide hydrolysis.
nant negative mutant for TCR signaling. This suggests Jurkat cells (107) were transiently transfected by electroporation, as
previously described (Wu et al., 1995), with 20 mg of the NF-AT orthat an effector domain of Vav is N-terminal to its SH3
Vav and SLP-76 in TCR Signaling
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IL-2 reporter plasmids and the indicated amount of vectors con- a yeast gene (CDC24) involved in cytoskeletal organization. Onco-
taining either no insert (pEFBOS), Vav (pEF115myc), SLP-76 (pEF/ gene 7, 611±618.
flag/SLP76), Vav±C (pEFVav±Cmyc), or Vav±CSH2RK (pEFVav± Boguski, M., and McCormick, F. (1993). Proteins regulating Ras and
CmycRK) cDNA inserts. TAg Jurkat cells were transiently its relatives. Nature 366, 643±654.
transfected by electroporation with 20 mg of the indicated plasmids
Boguski, M.S., Bairoch, A., Attwood, T.K., and Michaels, G.S. (1992).(either pEFBOS, pEF115myc, pEF115mycRK, or pEFVav±Cmyc) in
Proto-vav and gene expression [letter; comment]. Nature 358, 113.serum-free RPMI at a density of 2±3 3 107 cells/400 ml/cuvette with
a Bio-Rad gene pulser set at 250 V and 960 mF. After electroporation, Buday, L., Egan, S.E., Viciana, P.R., Cantrell, D.A., and Downward,
the cells were transferred to complete RPMI and incubated at 378C J. (1994). A complex of Grb2 adaptor protein, Sos exchange factor,
for 24±40 hr. and a 36-kDa membrane-bound tyrosine phosphoprotein is impli-
cated in ras activation in T cells. J. Biol. Chem. 269, 9019±9023.
Luciferase Assays Bustelo, X.R., and Barbacid, M. (1992). Tyrosine phosphorylation of
Transfected Jurkat cells (2 3 105) were aliquoted into a 96-well plate the vav proto-oncogene product in activated B cells. Science 256,
(Corning) 20±40 hr after transfection and cultured in a final volume
1196±1199.
of 100 ml RPMI growth medium. Cells were unstimulated or stimu-
Bustelo, X.R., Ledbetter, J.A., and Barbacid, M. (1992). Product oflated at 378C in the growth medium containing either 1:1000 dilution
vav proto-oncogene defines a new class of tyrosine protein kinaseof C305 ascites or 50 ng/ml phorbol myristate acetate (PMA) and
substrates. Nature 356, 68±71.1.0 mM ionomycin. After an 6±8 hr stimulation period, cells were
lysed in harvest buffer (100 mM KPO4 [pH 7.8], 1.0 mM DTT, 1% Bustelo, X.R., Suen, K., Leftheris, K., Meyers, C.A., and Barbacid,
Triton X-100) and 100 ml of lysate was mixed with 100 ml of assay M. (1994). Vav cooperates with Ras to transform rodent fibroblasts
buffer (200 mM KPO4 [pH 7.8], 10 mM ATP, 20 mM MgCl2). Luciferase but is not a Ras GDP/GTP exchange factor. Oncogene 9, 2405±2413.
activity was quantitated with a monolight luminometer (Analytical
Bustelo, X.R., Suen, K., Michael, W.M., Dreyfuss, G., and Barbacid,Luminescence Laboratory, Ann Arbor, Michigan) immediately after
M. (1995). Association of the vav proto-oncogene product withthe addition of 100 ml of 1.0 mM luciferin (Sigma Chemical Company,
poly(rC)-specific RNA-binding proteins. Mol. Cell. Biol. 15, 1324±St. Louis, Missouri). Luciferase activity was determined either in
1332.duplicate or in triplicate for each experimental condition.
Chan, A.C., Irving, B.A., Fraser, J.D., and Weiss, A. (1991). The
Immunoprecipitations, Protein Precipitations z-chain is associated with a tyrosine kinase and upon T cell antigen
Cells were harvested and washed in phosphate-buffered saline, and receptor stimulation associates with ZAP-70,a 70 kilodalton tyrosine
were left either unstimulated or stimulated with C305 ascites (1:500 phosphoprotein. Proc. Natl. Acad. Sci. USA 88, 9166±9170.
dilution) at 378C for 2 min or with pervanadate at room temperature Chan, A.C., Iwashima, M., Turck, C.W., and Weiss, A. (1992). ZAP-
for 10 min, and then lysed at 108/ml in the lysis buffer containing 70: a 70kDa protein tyrosine kinase that associates with the TCR z
1% NP40, 10 mM Tris (pH 7.8), 150 mM NaCl, 2 mM EDTA, protease chain. Cell 71, 649±662.
and phosphatase inhibitors, as previously described (Straus and
Chan, A.C., van Oers, N.S.C., Tran, A., Turka, L., Law, C.-L., Ryan,Weiss, 1992). After 20 min at 48C, lysates were centrifuged for 15
J.C., Clark, E.A., and Weiss, A. (1994). Differential expression ofmin at 14,000 rpm. Lysates were then immunoprecipitated with the
ZAP-70 and Syk protein tyrosine kinases, and the role of this familyindicated antibodies. When precipitated with GST fusion proteins,
of protein tyrosine kinases in T cell antigen receptor signaling. J.lysates were first precleared with GST alone before they were pre-
Immunol. 152, 4758±4766.cipitated with the indicated GST fusion proteins. Resulting immuno-
precipitates or protein complexes were then washed extensively in Clipstone, N.A., and Crabtree, G.R. (1992). Identification of cal-
lysis buffer, resolved by (SDS±PAGE), and transferred to polyvinyli- cineurin as a key signalling enzyme in T-lymphocyte activation. Na-
dene difluoride membranes. ture 357, 695±697.
Coppola, J., Bryant, S., Koda, T., Conway, D., and Barbacid, M.Immunoblots
(1991). Mechanism of activation of the vav proto-oncogene. CellBlots were blocked with 3% albumin in TBST buffer (10 mM Tris,
Growth Diff. 2, 95±105.[pH 7.9], 150 mM NaCl, with 0.05% Tween detergent). Blots were
incubated with the indicated antisera or MAb followed by a second- Evens, G.A., Howard, O.M., Erwin, R., and Farrar, W.L. (1993). In-
ary antibody conjugated with horseradish peroxidase and then as- terleukin-2 induces tyrosine phosphorylation of the vav proto-onco-
sayed by enhanced chemiluminescence assay (ECL kit; Amersham gene product in human T cells: lack of requirement for the tyrosine
Life Sciences, Arlington Heights, Illinois). In the case of reblotting kinase lck. Biochem. J. 294, 339±342.
with a different primary antibody, blots were incubated at 708C in Fischer, K.-D., Zmuldzinas, A., Gardner, S., Barbacid, M., Bernstein,
stripping buffer (2% SDS, 0.1 M 2-ME, 62.5 mM Tris [pH 6.8]) for
A., and Guidos, C. (1995). Defective T-cell receptor signalling and
20 min, washed extensively in TBST buffer, and then blocked and
positive selection of Vav-deficient CD41CD81 thymocytes. Natureprobed as described above.
374, 474±477.
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